Analytical Data
-
Gene name
FABP4
- Application
-
Alternative Names
A-FABP; AFABP; AP2; Fatty Acid Binding Protein 4, Adipocyte; Adipocyte Protein 2; Adipocyte-type fatty acid-binding protein
-
Species
Human
-
Source
HEK293
-
Tag
N-His
-
Purity
Greater than 95% as determined by SDS-PAGE.
-
Uniprot
P15090
-
Expression Region
Cys2~Ala132
-
Molecular Weight
16kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Fatty acid-binding protein 4 (FABP4), also known as adipocyte FABP, plays a crucial role in lipid metabolism, inflammation, and obesity-related diseases. It is predominantly expressed in adipose tissue and macrophages, where it facilitates the transport of fatty acids and other lipid signaling molecules. Research on FABP4 has gained significant attention due to its association with metabolic disorders such as insulin resistance, type 2 diabetes, and cardiovascular diseases. Recent studies have highlighted the protein's involvement in inflammatory responses and its potential as a biomarker for metabolic syndrome. The production of recombinant FABP4 proteins has become an essential tool for elucidating the molecular mechanisms underlying its biological functions. By leveraging recombinant DNA technology, scientists can produce large quantities of FABP4 for use in biochemical assays, structural biology investigations, and therapeutic applications. Understanding the structure-function relationship of FABP4 through recombinant protein studies can pave the way for the development of new therapeutic strategies aimed at mitigating obesity and its comorbidities. As such, the exploration of FABP4 recombinant proteins not only enhances our comprehension of fat metabolism and immune interactions but also holds promise for advancing clinical approaches to treat metabolic diseases.
